North America Point-of-Care Diagnostics Market 2026 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities

Market Size and Growth

The North America point-of-care diagnostics market size reached US$6.74 billion in 2024 and is expected to reach US$13.25 billion by 2033, growing at a CAGR of 7.9% during the forecast period 2025-2033.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/north-america-point-of-care-diagnostics-market?sb

Key Development:

United States: Recent Industry Developments

✅ In March 2026, Abbott strengthened its rapid and point-of-care diagnostics portfolio by expanding development of portable testing platforms for infectious disease and cardiometabolic monitoring. The initiative focuses on faster bedside testing solutions for hospitals, clinics, and home-care settings. It supports the shift toward decentralized diagnostics and real-time clinical decision-making.

✅ In February 2026, Thermo Fisher Scientific announced new investments in rapid molecular diagnostic technologies designed for near-patient testing environments. The development targets improved detection speed for infectious diseases and genetic conditions. It enhances availability of point-of-care solutions across emergency care and outpatient facilities.

✅ In January 2026, Roche expanded its U.S. diagnostics innovation program focused on compact testing systems used in urgent care centers and physician offices. The program supports integration of digital connectivity and automated result reporting. It aims to improve workflow efficiency and accelerate clinical decision support.

✅ In November 2025, Abbott announced the acquisition of Exact Sciences to strengthen its diagnostics business, including rapid and near-patient testing technologies used in early disease detection. The deal expands Abbott's capabilities in molecular and screening diagnostics. It reinforces its position in advanced and decentralized diagnostic solutions across North America.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=north-america-point-of-care-diagnostics-market

Canada: Recent Industry Developments

✅ In March 2026, Canada expanded funding for digital and point-of-care diagnostic technologies to support faster testing in remote and rural healthcare settings. The initiative focuses on portable testing systems that deliver immediate results without laboratory infrastructure. It improves accessibility of diagnostics across decentralized care environments.

✅ In February 2026, a Canadian research consortium introduced a microfluidic-based point-of-care testing device designed for rapid blood analysis at bedside and outpatient clinics. The system enables accurate biomarker measurement using compact cartridge-based technology. It supports faster diagnosis and monitoring of chronic and acute diseases.

✅ In January 2026, healthcare technology companies in Canada invested in AI-enabled point-of-care sensors capable of delivering rapid diagnostic results in emergency and primary care settings. The technology integrates portable readers with automated data analysis. It enhances clinical efficiency and reduces dependence on centralized laboratories.

✅ In September 2025, North American healthcare providers increased adoption of point-of-care molecular diagnostics for infectious disease testing in outpatient and urgent care centers. The expansion focuses on faster turnaround time and improved patient management. It accelerates the transition toward decentralized and real-time diagnostic testing.

Key Players:

=> BD, QuidelOrtho Corporation, QIAGEN, Trinity Biotech plc, BioMérieux SA, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott, Danaher Corporation, and Nova Biomedical, among others.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/north-america-point-of-care-diagnostics-market?sb

Key Segments:

By Product

Blood Glucose Products - 22% Share
Largest segment driven by increasing diabetes prevalence and high demand for home-based and hospital glucose monitoring devices.

Blood Gas & Electrolyte Products - 14% Share
Widely used in critical care and emergency settings for rapid analysis of patient condition.

Hematology Testing Products - 16% Share
Commonly used in routine blood testing, disease diagnosis, and health monitoring.

Urinalysis Products - 12% Share
Adopted for infection detection, kidney disorder diagnosis, and routine health screening.

Pregnancy & Fertility Testing Products - 10% Share
Growing demand due to increasing awareness of reproductive health and home testing kits.

Tumor / Cancer Profiling Products - 11% Share
Rising adoption for early cancer detection and personalized treatment planning.

Drug-of-Abuse Products - 8% Share
Used in hospitals, workplaces, and law enforcement for substance detection.

Others - 7% Share
Includes infectious disease testing and specialty diagnostic kits.

By Technology

Immunoassays - 38% Share
Leading technology due to high accuracy and wide use in infectious disease, hormone, and cancer testing.

Molecular Diagnostics - 30% Share
Fastest growing segment driven by demand for precise and early disease detection.

Microfluidics - 18% Share
Used in point-of-care testing devices due to rapid results and small sample requirement.

Others - 14% Share
Includes biosensors, chromatography, and emerging diagnostic technologies.

By Application

Hematology - 18% Share
High usage for routine blood testing and disease diagnosis.

Cardiology - 14% Share
Used for cardiac marker testing and monitoring heart-related conditions.

Endocrinology - 16% Share
Driven by increasing cases of diabetes and hormonal disorders.

Oncology - 15% Share
Growing demand for tumor detection and cancer monitoring tests.

Drug Testing - 12% Share
Used in clinical, workplace, and forensic testing.

Neurology - 10% Share
Adopted for detection of neurological disorders and biomarkers.

Others - 15% Share
Includes infectious diseases, kidney disorders, and metabolic testing.

By End-User

Hospitals & Clinics - 40% Share
Largest segment due to high patient volume and availability of advanced diagnostic equipment.

Diagnostic Laboratories - 30% Share
Widely used for specialized and high-volume testing services.

Ambulatory Surgery Centers (ASCs) - 12% Share
Growing use for rapid testing before and after surgical procedures.

Home Care Settings - 18% Share
Fastest growing segment due to increasing adoption of self-testing and portable diagnostic devices.

By Region

North America - 32% Share
Dominates due to advanced healthcare infrastructure and high adoption of diagnostic technologies.

Europe - 26% Share
Driven by strong healthcare systems and growing demand for early disease detection.

Asia Pacific - 28% Share
Fastest growing region due to rising healthcare spending and large patient population in China, India, and Japan.

South America - 7% Share
Growing demand for diagnostic services in urban healthcare centers.

Middle East & Africa - 7% Share
Increasing adoption of diagnostic devices in hospitals and private laboratories.

FAQ

What is the current size of the North America point-of-care diagnostics Market?

A: In 2024, the North America point-of-care diagnostics Market was valued at US$6.74 billion, reflecting its strong industry presence.

Q2: How large is the North America point-of-care diagnostics Market expected to be by 2033?

A: By 2033, industry forecasts suggest the North America point-of-care diagnostics Market will grow to around US$13.25 billion, demonstrating significant expansion.

Q3: What is the growth rate of the North America point-of-care diagnostics Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 7.9% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.